Rabbit Antibody to PC7 (paired basic amino acid cleaving enzyme-7, PC7, PCKS7, SPC7, C8, PC8, LPC); Amino end mature enzyme

RP2-PC7 is a rabbit polyclonal antibody made to the subtilisin-like serine protease PC7.  The antibody is made to a synthetic peptide based on the P-domain human PC7-A. The antibody has been peptide-affinity purified, concentrated to 1.0 mg/ml, with the addition of 0.05% sodium azide as preservative and 50% glycerol as cryoprotectant.

PC7 was the first described in the rat pituitary, and found to be expressed in many tissues including brain, adrenal gland, gut, ovary, testis, kidney, liver lung, thyroid and pancreas. A literature alias is C8 or PC8 . Two splice variants are reported; a 591 amino acid sequence (PC7-A) and a 785 amino acid membrane-associated form (PC7-B). The longer form is thought to be bound in the Golgi, and the shorter form secreted through dense core secretory granules. PC-7 has been shown to cleave parathyroid hormone and Tumor Necrosis Factor aloha converting enzyme (TACE, ADAM17). Like furin, PC1, PC2 and PACE4, PC7 is a serine proteinase that cleaves after pairs of basic amino acids, but with some differences in substrate specificity and distribution. The catalytic domain has homology to other PC enzymes, the prohormone convertase family initially discovered for their role in processing POMC, insulin and other pro-hormones, and later found to process a wider range of precursor proteins. Some have renamed the prohormone convertases as proprotein convertases, and another group has renamed the entire family with a uniform nomenclature of SPCs (subtilisin-like proprotein convertases), with PC7 getting the SPC7 moniker. PC7 structure contains a propeptide domain, a catalytic domain and an RGD containing cysteine-rich domain (homo-B). The longer sequence contains an extended cysteine-rich domain. The PCs have an RxxR consensus cleavage requirement, and the propeptide is separated from the mature protein by just such a sequence. After cleavage of the propeptide domain, PC7 becomes a two-chain form, and the propeptide piece is released after a second internal cleavage.  PC7-A resides mainly in the dense core secretory vesicles and the TGN, and is cycled to the surface, with some of the PC7 being secreted from the cells. The RP2PC-7 detects the short form of PC-7, not the long form. PC7 has been reported to be elevated in tumor cell lines and to increase tumor progression. The message for PC7-A encodes a 591 amino acid protein with a predicted mass of 64.4 kDa, and a pI of 5.9. The PC7-B protein has an apparent mass of 101 kDa on reduced SDS PAGE gels, and is processed to a secreted 89 kDa form. A recommended starting concentration for Western blots is 1:1,000 when using colorimetric substrates such as BCIP/NBT, and 1:5,000 for chemiluminescent substrates. 

FOR RESEARCH USE ONLY. NOT FOR USE IN HUMANS.

The undiluted antibody solution is stable for approximately 12 months at -20°C.

Triple Point Biologics products are sold exclusively through Abcam. For availability, pricing and buying information please select your country below and press 'Go'. You will be relocated to the relevant datasheet page on Abcam's website.